Pyxis secured S$13 million in the first close of its S$18 million growth funding round, reflecting strong investor confidence in its vessel technology, commercial traction, and regional growth ...
Pyxis Oncology Inc. (NASDAQ: PYXS) on Thursday released preliminary data from its ongoing Phase 1 studies of micvotabart pelidotin (MICVO) for recurrent/metastatic head and neck squamous cell ...
BOSTON - Pyxis Oncology, Inc. (NASDAQ:PYXS) announced preliminary data from ongoing Phase 1 clinical studies of its antibody-drug conjugate micvotabart pelidotin (MICVO) in patients with ...
With Windows 11’s November 2025 Update (update KB5068861), Microsoft fixed some bugs but also introduced some new issues. The biggest news item, however, was the introduction of a completely new and ...
LONDON, Nov. 18, 2025 /PRNewswire/ -- Compass Box Scotch Whiskymakers announce the launch of Pyxis, a first-of-its-kind AI-powered whisky guide designed to make exploration more personal, effortless, ...
At NAB 2025 in Las Vegas, Blackmagic Design announced the PYXIS 12K, a full-frame digital cinema camera with a 12K RGBW sensor, modular build, and cloud-based workflow tools. It’s priced at $4,995 and ...
Advanced digital film camera in a versatile design with revolutionary full frame 12K RGBW sensor in EF, PL or L-Mount, Blackmagic RAW and global media sync with Blackmagic Cloud! Blackmagic PYXIS 12K ...
Advanced digital film camera in a versatile design with revolutionary full frame 12K RGBW sensor in EF, PL or L-Mount, Blackmagic RAW and global media sync with Blackmagic Cloud! NAB 2025 -Blackmagic ...
Having recently trimmed back its pipeline to a sole cancer candidate, Pyxis Oncology has now reduced its head count to match. The Boston biotech is shrinking its workforce by "approximately" 20%, it ...
The completion of the $3.0 million common share repurchase program demonstrates Pyxis Tankers' commitment to returning value to shareholders and potentially enhancing share price. Redemption of all ...
Though Pyxis Oncology Inc.’s preliminary phase I data with antibody-drug conjugate (ADC) PYX-201 in solid tumors were characterized as positive, findings sent the Boston-based firm’s stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback